Comparison of the cytotoxic effects of receptor tyrosine kinase inhibitors on macrophage functions; possible side effects in the immune defense
- 15 November 2006
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 107 (2) , 169-175
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Receptor Tyrosine Kinases and Anticancer TherapyCurrent Pharmaceutical Design, 2005
- Newest findings on the oldest oncogene; how activated src does itJournal of Cell Science, 2004
- Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs): Simple drugs with a complex mechanism of action?Journal of Cellular Physiology, 2002
- Receptor Tyrosine Kinases as Target for Anti-Cancer TherapyCurrent Pharmaceutical Design, 2002
- Design of growth factor antagonists with antiangiogenic and antitumor propertiesOncogene, 2000
- Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine KinasesJournal of Medicinal Chemistry, 1998
- Dihydroorotate Dehydrogenase Inhibitors: Quantitative Structure-activity Relationship AnalysisPharmaceutical Research, 1998
- Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(α-phenethylamino)quinazolinesBioorganic & Medicinal Chemistry, 1995
- [(Alkylamino)methyl]acrylophenones: Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor Protein Tyrosine KinaseJournal of Medicinal Chemistry, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995